Drug Effects News

News

ProEx Physical Therapy Haverhill clinic to relocate to Bradford Plaza | PRLog
www.prlog.org | Feb 10, 2012
ProEx Physical Therapy Haverhill clinic to relocate to Bradford Plaza. Growth prompts move to larger 1500 square foot space in the Bradford Plaza at 3 Ferry Street. - PR11796179

David Eisele Named Director of Otolaryngology- Head and Neck Surgery at The Johns Hopkins Hospital
www.hopkinsmedicine.org | Feb 10, 2012
David W. Eisele, M.D., has been appointed the new director of Otolaryngology—Head and Neck Surgery at The Johns Hopkins Hospital and the Andelot Professor of Laryngology and Otology at the Johns Hopkins University School of Medicine. He will begin his tenure on March 1, 2012.

Vernalis secures backing for US drugs deal - FT.com
www.ft.com | Feb 10, 2012
Vernalis has raised more than three times its market capitalisation after investors backed a deal with a US pharmaceutical group to develop slow-release cough and cold medications. Shares in the lossmaking UK biotech company jumped by almost a third

Big Pharma: 3 To Avoid, 1 To Buy - Seeking Alpha
seekingalpha.com | Feb 10, 2012
< strong > By < a href='http://investmentunderground.com/' > Investment Underground < /a > : < /strong > < p > < em > By Robert Gordon < /em > < /p > < p > Large, mature pharmaceutical companies have long been Wall Street darlings. But most of the best known and best selling drugs from many of

All doctors should declare drug company payments: GSK | 6minutes
www.6minutes.com.au | Feb 10, 2012
Greater transparency is needed in the relationship between drug companies and the medical profession, according to pharma company GSK, as it considers the public disclosure of payments to individual doctors.

FDA Sets Draft Rules for Biotech Drug Copies
www.biospace.com | Feb 10, 2012
The U.S. Food and Drug Administration's long-awaited guidelines for the sale of lower-cost versions of biotechnology drugs leave open the possibility

FitchResearch
www.fitchratings.com | Feb 10, 2012
Fitch Ratings About Us Contact Us Press Room Events Help Search Sign in Autologin Printer-Friendly Page Click Here for Printer-Friendly Version Fitch Launches U.S. 'Navigating the Drug Channel' Report Series Endorsement Policy 10 Feb 2012 11:17 AM (EST) Fitch Ratings-Chicago-10 February 2012: Fitch

Ronnie Andrews, Life Technologi | Life Technologies appoints president of medical sciences |
www.pharmaasia.com | Feb 10, 2012
Life Technologies announced that Ronnie Andrews, former CEO of Clarient and Segment Leader, GE Molecular Diagnostics, has joined the company as president, medical sciences.

BBC News - Alzheimer's brain plaques 'rapidly cleared' in mice
www.bbc.co.uk | Feb 9, 2012
Destructive plaques found in the brains of Alzheimer's patients have been rapidly cleared by researchers testing a cancer drug on mice.

Study: Rapid bone loss as possible side effect of anti-obesity drug now in clinical trials
www.eurekalert.org | Feb 9, 2012
An endocrine hormone used in clinical trials as an anti-obesity and anti-diabetes drug causes significant and rapid bone loss in mice, raising concerns about its safe use, UT Southwestern Medical Center researchers have shown.